Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 73,743 | 430,605 | 26,754 | 14,662 | 212,803 |
| Marketable Securities | 940,403 | 594,568 | 631,277 | 631,631 | 438,960 |
| Receivables | N/A | N/A | N/A | 7,500 | 519 |
| TOTAL | $1,023,339 | $1,033,666 | $666,321 | $661,939 | $658,666 |
| Non-Current Assets | |||||
| PPE Net | 4,947 | 4,864 | 5,373 | 5,940 | 6,517 |
| Other Non-Current Assets | 22,486 | 22,986 | 23,325 | 23,533 | 23,801 |
| TOTAL | $27,433 | $27,850 | $28,698 | $29,473 | $30,318 |
| Total Assets | $1,050,772 | $1,061,516 | $695,019 | $691,412 | $688,984 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,351 | 4,026 | 2,462 | 1,253 | 2,254 |
| Accrued Expenses | 13,340 | 11,684 | 13,022 | 8,568 | 5,810 |
| TOTAL | $17,502 | $17,459 | $17,173 | $11,545 | $10,609 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 94 | 972 |
| Other Non-Current Liabilities | 20,801 | 21,276 | 21,742 | 22,190 | 22,612 |
| TOTAL | $20,801 | $21,276 | $21,742 | $22,190 | $22,612 |
| Total Liabilities | $38,303 | $38,735 | $38,915 | $33,735 | $33,221 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,175 | 59,105 | 52,482 | 52,165 | 51,851 |
| Common Shares | 59 | 59 | 52 | 52 | 51 |
| Retained earnings | -261,265 | -237,757 | -217,541 | -189,482 | -183,523 |
| Other shareholders' equity | 3,756 | 2,163 | 7,831 | -1,616 | -524 |
| TOTAL | $1,012,469 | $1,022,781 | $656,104 | $657,677 | $655,763 |
| Total Liabilities And Equity | $1,050,772 | $1,061,516 | $695,019 | $691,412 | $688,984 |